In the Boardroom
Refine Search
Biotechnology
US clinical-stage drug developer Acumen Pharmaceuticals has appointed Amy Schacterle as chief regulatory officer and head of quality, reporting to Jim Doherty, president and chief development officer at Acumen. 7 November 2024
Biotechnology
Memo Therapeutics, a privately-held Swiss biotech company translating unique responses into superior medicines to treat viral infections and cancer, has appointed a new chief development officer (CDO). 4 November 2024
Biotechnology
Netherlands-based Tessellate BIO, a pre-clinical stage biotech with a focus on novel synthetic lethality approaches, today announced the appointment of Dr Lara Boyd as chief business officer. 4 November 2024
Biotechnology
US biotech major Biogen revealed it has appointed Daniel Quirk as chief medical officer and head of medical affairs. 29 October 2024
Pharmaceutical
Fennec Pharmaceuticals has announced the addition of three new executives to bolster its leadership team as the company prepares for expanded commercial operations. 28 October 2024
Biotechnology
AAVantgarde has announced the appointment of Lauren Kaskiel as chief business officer (CBO). 22 October 2024
Pharmaceutical
British artificial intelligence specialist BenevolentAI has announced the return of its founder, Ken Mulvany, as executive chairman. 18 October 2024
Biotechnology
Denmark’s Commit Biologics, a specialist in the activation of the complement system to treat cancer and autoimmune disease, has announced the appointment of Mikkel Wandahl Pedersen as chief scientific officer (CSO). 15 October 2024
Pharmaceutical
Canada-based biotech Sernova (TSX: SVA) has announced key new appointments to its executive leadership team. 15 October 2024
Biotechnology
French biotech Innate Pharma has appointed Jonathan Dickinson as its new chief executive (CEO) and chairman of the executive board, effective November 1, 2024. 14 October 2024
Biotechnology
Turnstone Biologics has announced a major restructuring of its operations, cutting its workforce by approximately 60%. 14 October 2024
Pharmaceutical
Cancer start-up Black Diamond Therapeutics has announced a significant restructuring as part of its plan to focus resources on its lead drug, BDTX-1535. 10 October 2024
Biotechnology
Calluna Pharma, a biotech focused on treating inflammatory and fibrotic diseases, has appointed Mark Gaffney as its new chief executive. 9 October 2024
Biotechnology
Privately-held UK biotech Curve Therapeutics has announced the appointment of Rab Prinjha as chief research and development (R&D) officer. 9 October 2024
Biotechnology
French cancer vaccine focused biotech Oncovita has appointed Dr Stéphane Altaba as its new chief executive (CEO). 9 October 2024
Biotechnology
Cambridge, USA-based biotech Judo Bio has announced the company’s launch and $100 million in initial financing, including seed financing and Series A. 7 October 2024
Biotechnology
Mosaic Therapeutics, a UK-based oncology therapeutics company dedicated to resolving cancer’s complexity to power new combination therapies for patients, has announced the appointment of Barry Davies as chief scientific officer. 7 October 2024
Pharmaceutical
US pharma giant Pfizer (NYSE: PFE) has announced that John McGinley has been appointed UK managing director and country president. 7 October 2024
Pharmaceutical
ViroCell Biologics, a UK contract development and manufacturing organization (CDMO), has announces the appointment of Nicholas Ostrout, as vice president of corporate development and strategy. 7 October 2024
Generics
French pharma major Sanofi has chosen EUROAPI as the name for the future leading European company dedicated to the development, production and marketing of active pharmaceutical ingredients (API). 12 January 2021
Pharmaceutical
German life sciences company Bayer has named Sarena Lin the firm’s chief transformation and talent officer. 12 January 2021
Biotechnology
Innocoll Holdings, a specialty pharma company wholly-owned by Gurnet Point Capital, a private investment firm focused on health care, has named Louis Pascarella its new chief executive. 11 January 2021
Biotechnology
Austrian antiviral vaccine and immunodiagnostics specialist Viravaxx has appointed Helmut Brunar, former CEO and chairman at Axentis Pharma, as chief executive officer. 11 January 2021
Biotechnology
French biopharma Advicenne has named Peter Meeus its chief executive. 7 January 2021
Biotechnology
German privately-held vascular integrity company Adrenomed today revealed that Wolfgang Baiker has been appointed as chief executive (CEO) effective January 1, 2021. 4 January 2021
Biotechnology
US privately-held immunotherapy company ImmunityBio has appointed Fabio Benedetti as chief strategy officer, effective January 4, 2021. 31 December 2020
Biotechnology
Swedish company Alligator Bioscience has appointed Christina Reimer as chief medical officer. 29 December 2020
Biotechnology
Swedish Orphan Biovitrum, also known as Sobi, has appointed Duane Barnes as the new head of Sobi in North America. 22 December 2020
Biotechnology
South Korean contract development and manufacturing organization Samsung Biologics says that John Rim will become its president and chief executive, with immediate effect. 17 December 2020
Pharmaceutical
Privately-held Danish medical dermatology specialist LEO Pharma today announced that Jörg Möller will join its global leadership team as executive vice president, global research and development, effective January 1, 2021. 16 December 2020
Pharmaceutical
Novo Seeds, the early-stage investment and company creation team of Novo Holdings, has invested in a new portfolio company Hemab ApS, which is focused on the development of bispecific antibodies for the treatment of rare bleeding disorders. 14 December 2020
Pharmaceutical
A veteran of both pharma and digital health has been named the chief executive of Cognito Therapeutics. 10 December 2020
Pharmaceutical
The WHO Foundation, a newly-formed independent grant-making foundation, has appointed Anil Soni as its first chief executive officer. 7 December 2020
Biotechnology
French immunotherapy specialist Transgene said yesterday that its board had approved the appointment of Hedi Ben Brahim as its new chairman and chief executive, effective January 1, 2021. 4 December 2020
Biotechnology
UK-based rare diseases specialist Mereo BioPharma today announced the appointment of Dr Suba Krishnan as senior vice president of clinical development, effective December 7, 2020. 23 November 2020
Pharmaceutical
The new head of the European Medicines Agency, Emer Cooke, has formally started work in the role, kicking off a five-year renewable mandate as executive director. 16 November 2020
Pharmaceutical
Boehringer Ingelheim said today it has recently welcomed Yew Looi Liew (YL) as the newly-appointed president of US Human Pharma at its US headquarters, Boehringer Ingelheim Pharmaceuticals based in Ridgefield, CT, which is the German family-owned drug major’s largest US subsidiary. 30 October 2020
Pharmaceutical
German pharma major Bayer has appointed Christian Rommel as the new head of R&D at its pharmaceuticals division. 27 October 2020
Pharmaceutical
EXUMA Biotech Corporation, the company discovering and developing CAR-T products and delivery solutions for liquid and solid tumors, has announced an update to its senior leadership team. 19 October 2020
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze